People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cell Source, Inc. | — | Biotechnology | Series A | $13.9M | $113.9M | 2015 |
| CELL SOURCE Ltd | — | Biotechnology | Pre-Seed | $500K | $27.6M | 2013 |
David Zolty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Zolty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yoram Drucker | 2 | 6 |
| Ben Friedman | 2 | 3 |
| Itamar Shimrat | 2 | 2 |
| Dennis Brown | 1 | 5 |
| George Verstraete | 1 | 1 |
| Darlene Soave | 1 | 1 |
| Solomon Zolty | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.